Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8255)
All Articles published online
|
Publishing Process of This Article
|
Jun 14, 2015 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li YH, Yang LH, Sha KH, Liu TG, Zhang LG, Liu XX. Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis. World J Gastroenterol 2015; 21(22): 7008-7013 [PMID: 26078579 DOI: 10.3748/wjg.v21.i22.7008] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i22/7008.htm |
| Number | Citing Articles |
| 1 |
Ikuyo ICHI. Polyunsaturated Fatty Acid Deficiency Causes Alternative Metabolic System: Reveal the Important of Lipid Nutrition in Terms of Deficiency. KAGAKU TO SEIBUTSU 2021; 59(7): 333 doi: 10.1271/kagakutoseibutsu.59.333
|
| 2 |
Helen M. Parker, Jeffrey S. Cohn, Helen T. O’Connor, Manohar L. Garg, Ian D. Caterson, Jacob George, Nathan A. Johnson. Effect of Fish Oil Supplementation on Hepatic and Visceral Fat in Overweight Men: A Randomized Controlled Trial. Nutrients 2019; 11(2): 475 doi: 10.3390/nu11020475
|
| 3 |
Alimire Abulikemu, Xinying Zhao, Hailin Xu, Yan Li, Ru Ma, Qing Yao, Ji Wang, Zhiwei Sun, Yanbo Li, Caixia Guo. Silica nanoparticles aggravated the metabolic associated fatty liver disease through disturbed amino acid and lipid metabolisms-mediated oxidative stress. Redox Biology 2023; 59: 102569 doi: 10.1016/j.redox.2022.102569
|
| 4 |
Ma Ai Thanda Han, Osama Altayar, Shadi Hamdeh, Varun Takyar, Yaron Rotman, Ohad Etzion, Eric Lefebvre, Rifaat Safadi, Vlad Ratziu, Larry J. Prokop, Mohammad Hassan Murad, Mazen Noureddin. Rates of and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2019; 17(4): 616 doi: 10.1016/j.cgh.2018.06.011
|
| 5 |
Lygia N. Barroso, Jessica Salarini, Nathalie Carvalho Leite, Cristiane A. Villela-Nogueira, Alberto Dávalos, Maria das Graças Tavares Carmo, Wilza Arantes Ferreira Peres. Effect of fish oil supplementation on the concentration of miRNA-122, FGF-21 and liver fibrosis in patients with NAFLD: Study protocol for a randomized, double-blind and placebo-controlled clinical trial. Clinical Nutrition ESPEN 2023; 57: 117 doi: 10.1016/j.clnesp.2023.06.027
|
| 6 |
Kathy Musa-Veloso, Carolina Venditti, Han Youl Lee, Maryse Darch, Seth Floyd, Spencer West, Ryan Simon. Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease. Nutrition Reviews 2018; 76(8): 581 doi: 10.1093/nutrit/nuy022
|
| 7 |
Nicole Fakhoury-Sayegh, Hassan Younes, Gessica Heraoui, Raymond Sayegh. Nutritional Profile and Dietary Patterns of Lebanese Non-Alcoholic Fatty Liver Disease Patients: A Case-Control Study. Nutrients 2017; 9(11): 1245 doi: 10.3390/nu9111245
|
| 8 |
Zahra Orang, Mohammad Ali Mohsenpour, Hassan Mozaffari-Khosravi. Effect of Omega-3 fatty acid supplementation on inflammatory markers and insulin resistance indices in patient with type 2 diabetes and nonalcoholic fatty liver: A randomized double-blind clinical trial. Obesity Medicine 2020; 19: 100278 doi: 10.1016/j.obmed.2020.100278
|
| 9 |
Nada F. Abo El-Magd, Amro El-Karef, Mamdouh M. El-Shishtawy, Laila A. Eissa. Glycyrrhizin and Omega-3 fatty acids have hepatoprotective roles through toll-like receptor-4. Egyptian Journal of Basic and Applied Sciences 2019; 6(1): 82 doi: 10.1080/2314808X.2019.1669111
|
| 10 |
Jan W. Eriksson, Per Lundkvist, Per-Anders Jansson, Lars Johansson, Mats Kvarnström, Linda Moris, Tasso Miliotis, Gun-Britt Forsberg, Ulf Risérus, Lars Lind, Jan Oscarsson. Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study. Diabetologia 2018; 61(9): 1923 doi: 10.1007/s00125-018-4675-2
|
| 11 |
Donald B. Jump, Kelli A. Lytle, Christopher M. Depner, Sasmita Tripathy. Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease. Pharmacology & Therapeutics 2018; 181: 108 doi: 10.1016/j.pharmthera.2017.07.007
|
| 12 |
Elisabetta Schiano, Giuseppe Annunziata, Roberto Ciampaglia, Fortuna Iannuzzo, Maria Maisto, Gian Carlo Tenore, Ettore Novellino. Bioactive Compounds for the Management of Hypertriglyceridemia: Evidence From Clinical Trials and Putative Action Targets. Frontiers in Nutrition 2020; 7 doi: 10.3389/fnut.2020.586178
|
| 13 |
Cheng Han Ng, Mark D. Muthiah, Jieling Xiao, Yip Han Chin, Grace Lim, Wen Hui Lim, Phoebe Tay, Darren Jun Hao Tan, Jie Ning Yong, Xin‐Hui Pan, Jeffery Wei Heng Koh, Nicholas Chew, Nicholas Syn, Eunice Tan, Daniel Q. Huang, Mohammad Shadab Siddiqui, Rohit Loomba, Arun J. Sanyal, Mazen Noureddin. Meta‐analysis: analysis of mechanistic pathways in the treatment of non‐alcoholic steatohepatitis. Evidence from a Bayesian network meta‐analysis. Alimentary Pharmacology & Therapeutics 2022; 55(9): 1076 doi: 10.1111/apt.16808
|
| 14 |
Cheng Han Ng, Jieling Xiao, Wen Hui Lim, Yip Han Chin, Jie Ning Yong, Darren Jun Hao Tan, Phoebe Tay, Nicholas Syn, Roger Foo, Mark Chan, Nicholas Chew, Eunice XX Tan, Daniel Q. Huang, Yock Young Dan, Nobuharu Tamaki, Mohammad Shadab Siddiqui, Arun J. Sanyal, Rohit Loomba, Mazen Noureddin, Mark D. Muthiah. Placebo effect on progression and regression in NASH: Evidence from a meta‐analysis. Hepatology 2022; 75(6): 1647 doi: 10.1002/hep.32315
|
| 15 |
Van C Nguyen, Yuki Nakamura. Distinctly localized lipid phosphate phosphatases mediate endoplasmic reticulum glycerolipid metabolism in Arabidopsis. The Plant Cell 2023; 35(5): 1548 doi: 10.1093/plcell/koad021
|
| 16 |
Arpita Das, Yu Lung Malcolm Tang, Nora A. Althumiri, Vanessa Garcia-Larsen, Jörn M. Schattenberg, Saleh A. Alqahtani. Fatty acid composition but not quantity is an important indicator of non-alcoholic fatty liver disease: a systematic review. European Journal of Clinical Nutrition 2023; 77(12): 1113 doi: 10.1038/s41430-023-01335-2
|
| 17 |
Schohraya Spahis, Fernando Alvarez, Nejma Ahmed, Josée Dubois, Ramy Jalbout, Massimiliano Paganelli, Kelly Grzywacz, Edgard Delvin, Noel Peretti, Emile Levy. Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids. The Journal of Nutritional Biochemistry 2018; 58: 28 doi: 10.1016/j.jnutbio.2018.03.025
|
| 18 |
Rodrigo Valenzuela, Macarena Ortiz, María Catalina Hernández-Rodas, Francisca Echeverría, Luis Alberto Videla. Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease. Current Medicinal Chemistry 2020; 27(31): 5250 doi: 10.2174/0929867326666190410121716
|
| 19 |
Yajie Fu, Yanzhi Zhou, Linhu Shen, Xuewen Li, Haorui Zhang, Yeqi Cui, Ke Zhang, Weiguo Li, Wei-dong Chen, Shizhen Zhao, Yunfu Li, Wenling Ye. Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.973366
|
| 20 |
Guo Jia, Zou Qiong, Wang Yonghua. Health effects of omega-3 polyunsaturated fatty acids in common diseases. International Food Research Journal 2021; 28(6): 1098 doi: 10.47836/ifrj.28.6.01
|
| 21 |
Ratree Sawangjit, Bunchai Chongmelaxme, Pochamana Phisalprapa, Surasak Saokaew, Ammarin Thakkinstian, Kris V. Kowdley, Nathorn Chaiyakunapruk. Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD). Medicine 2016; 95(32): e4529 doi: 10.1097/MD.0000000000004529
|
| 22 |
Shruti Tarapure, Basavaraj R. Tubaki, Siddhi Khot. Elastographic liver evaluation of Katukyadi churna in the management of Non-Alcoholic Steatohepatitis (NASH) – A single arm clinical trial.. Journal of Ayurveda and Integrative Medicine 2021; 12(1): 136 doi: 10.1016/j.jaim.2020.12.015
|
| 23 |
Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Angela M Madden. Nutritional supplementation for non-alcohol-related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2018; doi: 10.1002/14651858.CD013157
|
| 24 |
Goh Eun Chung, Jiyoung Youn, Young Sun Kim, Jung Eun Lee, Sun Young Yang, Joo Hyun Lim, Ji Hyun Song, Eun Young Doo, Joo Sung Kim. Dietary patterns are associated with the prevalence of nonalcoholic fatty liver disease in Korean adults. Nutrition 2019; 62: 32 doi: 10.1016/j.nut.2018.11.021
|
| 25 |
Francisca Herrera Vielma, Rodrigo Valenzuela, Luis A. Videla, Jessica Zúñiga-Hernández. N-3 Polyunsaturated Fatty Acids and Their Lipid Mediators as A Potential Immune–Nutritional Intervention: A Molecular and Clinical View in Hepatic Disease and Other Non-Communicable Illnesses. Nutrients 2021; 13(10): 3384 doi: 10.3390/nu13103384
|
| 26 |
Javad Heshmati, Mojgan Morvaridzadeh, Saman Maroufizadeh, Abolfazl Akbari, Mahsa Yavari, Ali Amirinejad, Arezoo Maleki-Hajiagha, Mahdi Sepidarkish. Omega-3 fatty acids supplementation and oxidative stress parameters: A systematic review and meta-analysis of clinical trials. Pharmacological Research 2019; 149: 104462 doi: 10.1016/j.phrs.2019.104462
|
| 27 |
Xuehui Li, Chengjie Liu, Ru Zhang, Yi Li, Ding Ye, Houpeng Wang, Mudan He, Yonghua Sun. Biosynthetic deficiency of docosahexaenoic acid causes nonalcoholic fatty liver disease and ferroptosis-mediated hepatocyte injury. Journal of Biological Chemistry 2024; 300(7): 107405 doi: 10.1016/j.jbc.2024.107405
|
| 28 |
Laura Pletsch-Borba, Charlotte Wernicke, Jürgen Machann, Nina MT. Meyer, Thu Huong Nguyen, Anne Pohrt, Silke Hornemann, Christiana Gerbracht, Andreas FH. Pfeiffer, Joachim Spranger, Knut Mai. Increase in PUFA and protein, and decrease in carbohydrate intake improves liver fat in 12 months and the role of weight loss as a mediator: A randomized controlled trial. Clinical Nutrition 2024; 43(12): 361 doi: 10.1016/j.clnu.2024.11.010
|
| 29 |
Kátia Cansanção, Marta Citelli, Nathalie Carvalho Leite, María-Carmen López de las Hazas, Alberto Dávalos, Maria das Graças Tavares do Carmo, Wilza Arantes Ferreira Peres. Impact of Long-Term Supplementation with Fish Oil in Individuals with Non-Alcoholic Fatty Liver Disease: A Double Blind Randomized Placebo Controlled Clinical Trial. Nutrients 2020; 12(11): 3372 doi: 10.3390/nu12113372
|
| 30 |
Laís Vales Mennitti, Lila Missae Oyama, Aline Boveto Santamarina, Oller do Nascimento, Luciana Pellegrini Pisani. Influence of maternal consumption of different types of fatty acids during pregnancy and lactation on lipid and glucose metabolism of the 21-day-old male offspring in rats. Prostaglandins, Leukotrienes and Essential Fatty Acids 2018; 135: 54 doi: 10.1016/j.plefa.2018.07.001
|
| 31 |
Xiao-fei Guo, Wen-Jun Ma. Advances in Dietary Lipids and Human Health. 2022; : 135 doi: 10.1016/B978-0-12-823914-8.00009-4
|
| 32 |
Bianca M. Arendt, Anastasia Teterina, Paulina Pettinelli, Elena M. Comelli, David W.L. Ma, Scott K. Fung, Ian D. McGilvray, Sandra E. Fischer, Johane P. Allard. Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease. Nutrition 2019; 62: 100 doi: 10.1016/j.nut.2018.12.001
|
| 33 |
Oluyemi Komolafe, Elena Buzzetti, Audrey Linden, Lawrence MJ Best, Angela M Madden, Danielle Roberts, Thomas JG Chase, Dominic Fritche, Suzanne C Freeman, Nicola J Cooper, Alex J Sutton, Elisabeth Jane Milne, Kathy Wright, Chavdar S Pavlov, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2021; 2021(7) doi: 10.1002/14651858.CD013157.pub2
|
| 34 |
Mohamed Abdallah, Landon Brown, John Provenza, Raseen Tariq, Smitha Gowda, Ashwani K. Singal. Safety and efficacy of dyslipidemia treatment in NAFLD patients: a meta-analysis of randomized controlled trials. Annals of Hepatology 2022; 27(6): 100738 doi: 10.1016/j.aohep.2022.100738
|
| 35 |
Priscila Silva Figueiredo, Aline Carla Inada, Gabriela Marcelino, Carla Maiara Lopes Cardozo, Karine De Cássia Freitas, Rita De Cássia Avellaneda Guimarães, Alinne Pereira de Castro, Valter Aragão do Nascimento, Priscila Aiko Hiane. Fatty Acids Consumption: The Role Metabolic Aspects Involved in Obesity and Its Associated Disorders. Nutrients 2017; 9(10): 1158 doi: 10.3390/nu9101158
|
| 36 |
Silvia Godea, Diana Ciubotariu, Mihai Danciu, Raoul Vasile Lupușoru, Cristina Mihaela Ghiciuc, Irina Cernescu, Nicolae Gheţu, Mihai Lupei, Cătălina Elena Lupușoru. Improvement in serum lipids and liver morphology after supplementation of the diet with fish oil is more evident under regular feeding conditions than under high-fat or mixed diets in rats. Lipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01339-y
|
| 37 |
Jinchunzi Yang, Marta Fernández-Galilea, Leyre Martínez-Fernández, Pedro González-Muniesa, Adriana Pérez-Chávez, J. Alfredo Martínez, Maria J. Moreno-Aliaga. Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation. Nutrients 2019; 11(4): 872 doi: 10.3390/nu11040872
|
| 38 |
Thomas Marjot, Ahmad Moolla, Jeremy F Cobbold, Leanne Hodson, Jeremy W Tomlinson. Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management. Endocrine Reviews 2020; 41(1): 66 doi: 10.1210/endrev/bnz009
|
| 39 |
Bruna Vidal Dias, Sttefany Viana Gomes, Maria Laura da Cruz Castro, Luana Cristina Faria Carvalho, Gustavo Silveira Breguez, Débora Maria Soares de Souza, Camila de Oliveira Ramos, Marcella Ramos Sant'Ana, Susana Castelo Branco Ramos Nakandakari, Carolina Morais Araujo, Andrea Grabe-Guimarães, André Talvani, Cláudia Martins Carneiro, Dennys Esper Corrêa Cintra, Daniela Caldeira Costa. EPA/DHA and linseed oil have different effects on liver and adipose tissue in rats fed with a high-fat diet. Prostaglandins & Other Lipid Mediators 2022; 159: 106622 doi: 10.1016/j.prostaglandins.2022.106622
|
| 40 |
Xiao-fei Guo, Bo Yang, Jun Tang, Duo Li. Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials. Clinical Nutrition 2018; 37(1): 113 doi: 10.1016/j.clnu.2017.01.003
|
| 41 |
Hira Hanif, Muzammil M. Khan, Mukarram J. Ali, Pir A. Shah, Jinendra Satiya, Daryl T.Y. Lau, Aysha Aslam. A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B. Microorganisms 2020; 8(10): 1526 doi: 10.3390/microorganisms8101526
|
| 42 |
Rosa Lombardi, Simona Onali, Douglas Thorburn, Brian R Davidson, Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis. Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD). Cochrane Database of Systematic Reviews 2017; 2017(4) doi: 10.1002/14651858.CD011640.pub2
|
| 43 |
Jian-Gao Fan, Seung-Up Kim, Vincent Wai-Sun Wong. New trends on obesity and NAFLD in Asia. Journal of Hepatology 2017; 67(4): 862 doi: 10.1016/j.jhep.2017.06.003
|
| 44 |
Leanne Hodson, Fredrik Rosqvist, Siôn A Parry. The influence of dietary fatty acids on liver fat content and metabolism. Proceedings of the Nutrition Society 2020; 79(1): 30 doi: 10.1017/S0029665119000569
|
| 45 |
Syifa Mustika, Evira Rahma Aya Sofia, Novita Apramadha Kartika Sari, Levrita Nindya Poetri, Hendy Setyo Yudhanto, Dian Handayani. The Effects of Traditional Asian Diet on Metabolism, Gut Microbiota, and Liver Tissue in NASH Rats. Natural and Engineering Sciences 2024; 9(2): 309 doi: 10.28978/nesciences.1574444
|
| 46 |
Tannaz Eslamparast, Puneeta Tandon, Maitreyi Raman. Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease. Nutrients 2017; 9(8): 800 doi: 10.3390/nu9080800
|
| 47 |
Eleonora Scorletti, Christopher D. Byrne. Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action. Molecular Aspects of Medicine 2018; 64: 135 doi: 10.1016/j.mam.2018.03.001
|
| 48 |
Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Angela M Madden. Lifestyle modifications for non-alcohol related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2018; doi: 10.1002/14651858.CD013156
|
| 49 |
Elliot B. Tapper, Charlotte Fleming, Adriana Rendon, João Fernandes, Pierre Johansen, Margarida Augusto, Sunita Nair. The Burden of Nonalcoholic Steatohepatitis: A Systematic Review of Epidemiology Studies. Gastro Hep Advances 2022; 1(6): 1049 doi: 10.1016/j.gastha.2022.06.016
|
| 50 |
Aneta Sokal-Dembowska, Sara Jarmakiewicz-Czaja, Katarzyna Ferenc, Rafał Filip. Can Nutraceuticals Support the Treatment of MASLD/MASH, and thus Affect the Process of Liver Fibrosis?. International Journal of Molecular Sciences 2024; 25(10): 5238 doi: 10.3390/ijms25105238
|
| 51 |
Nirvair S. Kelley. Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans. Metabolic Syndrome and Related Disorders 2016; 14(9): 417 doi: 10.1089/met.2016.0051
|
| 52 |
SM Jeyakumar, A Vajreswari. Dietary Interventions in Liver Disease. 2019; : 373 doi: 10.1016/B978-0-12-814466-4.00030-6
|
| 53 |
Gabriela S. de Castro, Philip C. Calder. Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. Clinical Nutrition 2018; 37(1): 37 doi: 10.1016/j.clnu.2017.01.006
|
| 54 |
Renate L. Hall, Elena S. George, Audrey C. Tierney, Anjana J. Reddy. Effect of Dietary Intervention, with or without Cointerventions, on Inflammatory Markers in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Advances in Nutrition 2023; 14(3): 475 doi: 10.1016/j.advnut.2023.01.001
|
| 55 |
Xi-Xi He, Xiao-Li Wu, Ren-Pin Chen, Chao Chen, Xiao-Gang Liu, Bin-Jiao Wu, Zhi-Ming Huang, Jonathan M Peterson. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials. PLOS ONE 2016; 11(10): e0162368 doi: 10.1371/journal.pone.0162368
|
| 56 |
Elena Buzzetti, Audrey Linden, Lawrence MJ Best, Angela M Madden, Danielle Roberts, Thomas J G Chase, Suzanne C Freeman, Nicola J Cooper, Alex J Sutton, Dominic Fritche, Elisabeth Jane Milne, Kathy Wright, Chavdar S Pavlov, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2021; 2021(6) doi: 10.1002/14651858.CD013156.pub2
|
| 57 |
Elisabetta Schiano, Fortuna Iannuzzo, Mariano Stornaiuolo, Fabrizia Guerra, Gian Carlo Tenore, Ettore Novellino. Gengricin®: A Nutraceutical Formulation for Appetite Control and Therapeutic Weight Management in Adults Who Are Overweight/Obese. International Journal of Molecular Sciences 2024; 25(5): 2596 doi: 10.3390/ijms25052596
|
| 58 |
Jian-Hui Yan, Bing-Jie Guan, Hai-Yan Gao, Xian-E Peng. Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease. Medicine 2018; 97(37): e12271 doi: 10.1097/MD.0000000000012271
|
| 59 |
IL Labuschagne, R Blaauw. An anti-inflammatory approach to the dietary management of multiple sclerosis: a condensed review. South African Journal of Clinical Nutrition 2018; 31(3): 67 doi: 10.1080/16070658.2018.1465652
|
| 60 |
Wenjuan Liao, Hongbing Liu, Yiwei Zhang, Ji Hoon Jung, Jiaxiang Chen, Xiaohua Su, Yeong C. Kim, Elsa R Flores, San Ming Wang, Malwina Czarny-Ratajczak, Wen Li, Shelya X. Zeng, Hua Lu. Ccdc3: A New P63 Target Involved in Regulation Of Liver Lipid Metabolism. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-09228-8
|
| 61 |
Cheng Xiao, Siliang Chen, Chunru Yang, Jieying Liu, Miao Yu. Identification of polyunsaturated fatty acids related key modules and genes in metabolic dysfunction-associated fatty liver disease using WGCNA analysis. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.951224
|
| 62 |
Mahsa Zebardast, Fatemeh Kheradmand, Parviz Ranjbarvan, Ali Golchin. Assessing evening primrose oil effects on the serum levels of omentin-1 and biochemical parameters in the diabetic rat model. Comparative Clinical Pathology 2023; 33(2): 193 doi: 10.1007/s00580-023-03538-2
|